Comparison of Microbiome Composition and Biomarkers in Pharmaco Resistant and Pharmaco-Sensitive Epilepsy

Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

NCT03336242 ·Status: TERMINATED ·Phase: PHASE2

Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies

NCT02239276 ·Status: NO_LONGER_AVAILABLE

Role of the Gut Microbiota in Pediatric Epilepsy

NCT04705298 ·Status: UNKNOWN ·Phase: PHASE4

Epidiolex and Drug Resistant Epilepsy in Children

NCT02397863 ·Status: AVAILABLE

Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study

NCT06736002 ·Status: RECRUITING ·Phase: NA

Application of Novel Diagnostic and Therapeutical Methods in Epilepsy and Neurodevelopmental Abnormalities in Children.

NCT03486366 ·Status: UNKNOWN ·Phase: NA

EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE

NCT07253701 ·Status: RECRUITING

Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures

NCT02849626 ·Status: COMPLETED ·Phase: PHASE3

Human Epilepsy Project 2: Resistant Focal Seizures Study

NCT03531008 ·Status: COMPLETED

The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients

NCT03403907 ·Status: COMPLETED ·Phase: NA

Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy

NCT05160350 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

NCT01527006 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

NCT03208660 ·Status: COMPLETED

BOTOX Effects on Seizure Severity and Susceptibility

NCT05605756 ·Status: TERMINATED ·Phase: PHASE4

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

NCT03059329 ·Status: COMPLETED

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

NCT00567424 ·Status: WITHDRAWN ·Phase: PHASE2

Human Epilepsy Project 3

NCT05374928 ·Status: ACTIVE_NOT_RECRUITING

A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy

NCT03603639 ·Status: TERMINATED ·Phase: PHASE2

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

NCT02736162 ·Status: COMPLETED

Protocol Establishment for the Prevention of Lamotrigine-induced Skin Rash in Epilepsy Patients

NCT03220256 ·Status: UNKNOWN ·Phase: PHASE2

The Modified Ketogenic Diet for the Treatment of Pharmacoresistant Epilepsy in Adults

NCT03425110 ·Status: UNKNOWN

Seizure Advisory System Feasibility Study

NCT01043406 ·Status: TERMINATED ·Phase: PHASE1

An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

NCT02607904 ·Status: COMPLETED ·Phase: PHASE2

Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies

NCT03166215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

NCT05364021 ·Status: COMPLETED ·Phase: PHASE1/PHASE2